Biosyent Inc. sees steady gains as it navigates recent market developments.
Biosyent Inc. (RX.V) has seen a modest rise in its stock price this week, reflecting ongoing investor interest amidst recent corporate activities. The stock closed at C$15.98, marking a 0.82% increase for both the day and the week, and a notable 25.24% rise year-to-date.
Investor takeaway: Biosyent's acquisition of Oral Science Inc. and consistent dividend declarations may enhance its appeal to investors, although the stock remains within a tight 52-week range.
Advertisement
Biosyent Inc.
RX.V
RX.V
Biosyent Inc.
WealthAwesomeMarket cap
$189.83M
P/E
19.9x
Div. yield
1.25%
Div. / share
$0.21
52W high
$17.50
52W low
$10.49
1W change
+2.52%
Beta
0.59
Analyst Price Targets
Based on analyst covering RX · as of Sep 17, 2026
Wall Street analysts forecast RX stock price to rise 6.4% over the next 12 months.
Consensus
Moderately BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$18.00
+6.4% Upside
Current Price
C$16.91
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on RX's historical volatility
30-Day Vol
35.9%
Annualized
90-Day Vol
29.7%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$20.22
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$17.95 | C$15.86 – C$20.32 |
| 60 trading days | C$19.05 | C$15.99 – C$22.70 |
| 90 trading days | C$20.22 | C$16.31 – C$25.07 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Biosyent Inc. Stock Up 25.24% Year-to-Date
The stock has shown consistent growth, with a year-to-date increase of 25.24%, reflecting strong market confidence in the company's strategic direction.
Bull case
The recent acquisition of Oral Science Inc. could diversify Biosyent's product offerings and boost revenue streams, making it attractive to investors seeking growth in the healthcare sector.
Bear case
Despite these positive movements, the stock's performance remains limited within its 52-week range, indicating potential volatility and the need for cautious investment strategies.
Recent Price Action
Advertisement
Biosyent Inc. stock closed at C$15.98, reflecting a 0.82% increase for the day and the week. The stock has gained 4.79% over the past month and boasts a significant 25.24% increase year-to-date, indicating strong momentum as investors respond positively to the company's recent activities.
Company News and Catalysts
While there were no major announcements this week, the recent acquisition of Oral Science Inc. for $25.5 million could be a significant growth driver for Biosyent. This acquisition aims to enhance their product offerings in dental hygiene and oral health, which may lead to increased sales and market expansion. Additionally, the company has consistently declared dividends, with the latest being a quarterly dividend of $0.055 per share, payable on March 13, 2026. This commitment to returning value to shareholders is likely to maintain investor confidence.
Technical Picture
Biosyent's current price is above both its 50-day moving average (C$15.08) and 200-day moving average (C$14.24), indicating a bullish trend. The stock has traded within a 52-week range of C$10.49 to C$16.25, currently sitting at about 95% of this range. With a beta of 0.64, the stock has shown lower volatility compared to the broader market. The recent trading volume of 5,000 shares is below the 20-day average of 7,478 shares, suggesting a quieter trading environment.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
